CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr | ₹11,798 Cr |
What is the latest Appropriations of CIPLA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹22,179 Cr |
| Mar2024 | ₹18,471 Cr |
| Mar2023 | ₹16,054 Cr |
| Mar2022 | ₹13,523 Cr |
| Mar2021 | ₹11,798 Cr |
How is Appropriations of CIPLA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹22,179 Cr | 20.07 | |
| Mar2024 | ₹18,471 Cr | 15.06 | |
| Mar2023 | ₹16,054 Cr | 18.72 | |
| Mar2022 | ₹13,523 Cr | 14.62 | |
| Mar2021 | ₹11,798 Cr | - | |
Compare Appropriations of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹97,024.9 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹83,352.1 Cr | -1% | -10.1% | -18.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.3% |
-11.2% |
-19.5% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses